Certolizumab pegol/methotrexateDigestive intolerance and disseminated tuberculosis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1895卷 / 1期

关键词：

D O I：

10.1007/s40278-022-10549-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：124 / 124

相关论文

共 50 条

[1] Adalimumab/certolizumab pegol/infliximabDisseminated tuberculosis: case report
[J]. Reactions Weekly, 2017, 1682 (1) : 20 - 20
[2] Certolizumab pegol/methotrexatePancytopenia: case report
[J]. Reactions Weekly, 2014, 1492 (1) : 16 - 16
[3] Certolizumab pegol/leflunomidePyomyositis: case report
[J]. Reactions Weekly, 2018, 1720 (1) : 73 - 73
[4] Adalimumab/certolizumab pegol/infliximabPsoriasis: case report
[J]. Reactions Weekly, 2016, 1586 (1) : 23 - 23
[5] Certolizumab pegol/infliximabPsoriasiform lesions: case report
[J]. Reactions Weekly, 2015, 1564 (1) : 48 - 48
[6] Certolizumab pegol/mercaptopurine/mesalazineAplastic anaemia?: case report
[J]. Reactions Weekly, 2010, 1325 (1) : 12 - 12
[7] Certolizumab pegol/isoniazidTuberculosis and lack of efficacy: case report
[J]. Reactions Weekly, 2022, 1928 (1) : 122 - 122
[8] Adalimumab/certolizumab-pegol/infliximabPsoriasis : case report
[J]. Reactions Weekly, 2016, 1595 (1) : 15 - 15
[9] Certolizumab-pegol/infliximabLack of efficacy: case report
[J]. Reactions Weekly, 2023, 1956 (1) : 139 - 139
[10] Certolizumab-pegol/methotrexateLiver injury: case report
[J]. Reactions Weekly, 2023, 1982 (1) : 123 - 123

← 1 2 3 4 5 →